TherapeuticsMD, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
TherapeuticsMD, Inc. (TXMD) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 48.30% for the 12-month period ending 2024-12-31, per its 10-K/A filed 2026-04-01.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-04-01
- TherapeuticsMD, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was 48.30%.
- TherapeuticsMD, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -274.60%, a 111.59% decline from fiscal 2022.
- TherapeuticsMD, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was 2368.50%.
- TherapeuticsMD, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was -4.60%, a 675.00% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 48.30% 10-K/A · filed 2026-04-01 | |
| 2023-12-31 | -274.60% 10-K · filed 2025-03-27 | |
| 2022-12-31 | 2368.50% 10-K · filed 2024-03-29 | |
| 2021-12-31 | -4.60% 10-K · filed 2023-04-07 | -2.10% 10-K · filed 2022-03-23 |
| 2020-12-31 | 0.80% 10-K · filed 2022-03-23 | |
| 2019-12-31 | -2.70% 10-K · filed 2022-03-23 | |
| 2018-12-31 | -0.30% 10-K · filed 2021-03-04 | |
| 2017-12-31 | -0.80% 10-K · filed 2020-02-24 | |
| 2016-12-31 | 0.90% 10-K · filed 2019-02-27 | |
| 2015-12-31 | 0.24% 10-K · filed 2018-02-23 | |
| 2014-12-31 | 11.10% 10-K · filed 2017-02-28 | |
| 2013-12-31 | -8.40% 10-K · filed 2016-02-26 | |
| 2012-12-31 | -22.30% 10-K · filed 2015-03-12 | |
| 2011-12-31 | -29.20% 10-K · filed 2014-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |